XML 87 R77.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT REPORTING - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Total revenues $ 87,208 $ 84,117
Cost of sales (excluding depreciation and amortization and stock compensation expense) 39,513 41,759
Product development 8,247 10,689
Sales and marketing 5,409 6,592
General and administrative expenses 19,464 19,396
Total expenses 79,048 84,705
Total Adjusted EBITDA 18,231 10,324
Operating Segments    
Segment Reporting Information [Line Items]    
Total expenses 68,977 73,793
Financial Health    
Segment Reporting Information [Line Items]    
Total revenues 56,133 53,439
Cost of sales (excluding depreciation and amortization and stock compensation expense) 27,192 29,597
Financial Health | Operating Segments    
Segment Reporting Information [Line Items]    
Total revenues 56,133 53,439
Cost of sales (excluding depreciation and amortization and stock compensation expense) 27,073 29,523
Product development 3,109 2,427
Sales and marketing 3,830 4,282
General and administrative expenses 10,840 10,410
Total expenses 44,852 46,642
Total Adjusted EBITDA 11,281 6,797
Patient Care    
Segment Reporting Information [Line Items]    
Total revenues 31,075 30,678
Cost of sales (excluding depreciation and amortization and stock compensation expense) 12,321 12,162
Patient Care | Operating Segments    
Segment Reporting Information [Line Items]    
Total revenues 31,075 30,678
Cost of sales (excluding depreciation and amortization and stock compensation expense) 12,241 12,202
Product development 4,930 8,049
Sales and marketing 1,395 2,171
General and administrative expenses 5,559 4,729
Total expenses 24,125 27,151
Total Adjusted EBITDA $ 6,950 $ 3,527